— Know what they know.
Not Investment Advice

SCYX NASDAQ

SCYNEXIS, Inc.
1W: +16.6% 1M: -1.9% 3M: +8.2% YTD: +701.9% 1Y: +533.4% 3Y: +142.7% 5Y: -8.2%
$5.12
-0.25 (-4.66%)
 
Weekly Expected Move ±11.7%
$4 $5 $5 $6 $6
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 53 · $32.2M mcap · 6M float · 3.97% daily turnover · Short 54% of daily vol

📊 Key Metrics

TTM
$19M
Revenue
+489.8% YoY
$-10M
Net Income
+47.6% YoY
$-13M
Free Cash Flow
+44.8% YoY
100.0%
Gross Margin
-3308.5%
Op. Margin
3147.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-18.4%
ROA-15.1%
ROIC-120.7%

Valuation

P/E-2.8
P/B0.9
EV/EBITDA2.2

Leverage

Debt/Equity0.03
Current Ratio9.65
Interest Cov.0.0x

Quality Scores

Piotroski F5/9
Altman Z-3.25
Beneish M-2.72

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms